WO1998036732A3 - Preparation combinee pour antibiotiques administrables par voie orale - Google Patents

Preparation combinee pour antibiotiques administrables par voie orale Download PDF

Info

Publication number
WO1998036732A3
WO1998036732A3 PCT/EP1998/000029 EP9800029W WO9836732A3 WO 1998036732 A3 WO1998036732 A3 WO 1998036732A3 EP 9800029 W EP9800029 W EP 9800029W WO 9836732 A3 WO9836732 A3 WO 9836732A3
Authority
WO
WIPO (PCT)
Prior art keywords
component
orally administered
combination preparation
administered antibiotics
antibiotics
Prior art date
Application number
PCT/EP1998/000029
Other languages
German (de)
English (en)
Other versions
WO1998036732A2 (fr
Inventor
Ulrich Posanski
Original Assignee
Glf Galenik Labor Gmbh
Ulrich Posanski
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glf Galenik Labor Gmbh, Ulrich Posanski filed Critical Glf Galenik Labor Gmbh
Priority to AU60926/98A priority Critical patent/AU6092698A/en
Priority to EP98905269A priority patent/EP0971691A2/fr
Publication of WO1998036732A2 publication Critical patent/WO1998036732A2/fr
Publication of WO1998036732A3 publication Critical patent/WO1998036732A3/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

L'invention concerne une préparation combinée pour administration orale d'antibiotiques en suspension aqueuse, renfermant a) un composant formé d'une matière active, sous forme de particules enrobées par un agent d'enrobage polymère, perméable, apte au gonflement et/ou soluble dans les sucs gastriques, et b) une base de sirop, de pH 5 à 10, en tant que deuxième composant séparé du premier composant a). Les deux composants sont contenus dans deux réceptacles séparés qui sont présentés dans un emballage commun du type 'nécessaire d'éléments composants'.
PCT/EP1998/000029 1997-02-21 1998-01-05 Preparation combinee pour antibiotiques administrables par voie orale WO1998036732A2 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
AU60926/98A AU6092698A (en) 1997-02-21 1998-01-05 Combination preparation for orally administered antibiotics
EP98905269A EP0971691A2 (fr) 1997-02-21 1998-01-05 Preparation combinee pour antibiotiques administrables par voie orale

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19706978.9 1997-02-21
DE1997106978 DE19706978A1 (de) 1997-02-21 1997-02-21 Kombinationspräparat für oral applizierbare Antibiotika

Publications (2)

Publication Number Publication Date
WO1998036732A2 WO1998036732A2 (fr) 1998-08-27
WO1998036732A3 true WO1998036732A3 (fr) 1998-10-22

Family

ID=7821094

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP1998/000029 WO1998036732A2 (fr) 1997-02-21 1998-01-05 Preparation combinee pour antibiotiques administrables par voie orale

Country Status (4)

Country Link
EP (1) EP0971691A2 (fr)
AU (1) AU6092698A (fr)
DE (1) DE19706978A1 (fr)
WO (1) WO1998036732A2 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6551616B1 (en) 1997-04-11 2003-04-22 Abbott Laboratories Extended release formulations of erythromycin derivatives
GB9815532D0 (en) * 1998-07-17 1998-09-16 Lek Pharmaceutical & Cvhemical Pharmaceutical suspension formulation
GB9930578D0 (en) * 1999-12-23 2000-02-16 Smithkline Beecham Plc Pharmaceutical formulations
WO2003053399A2 (fr) * 2001-12-21 2003-07-03 Pfizer Products Inc. Procedes de granulation par voie humide d'azithromycine
JP2014521714A (ja) 2011-08-12 2014-08-28 ベーリンガー インゲルハイム フェトメディカ ゲゼルシャフト ミット ベシュレンクテル ハフツング ネコ科動物の心不全を治療および予防する方法において使用するための奇異性電流（Ｉｆ）阻害薬
WO2014122248A1 (fr) 2013-02-11 2014-08-14 Boehringer Ingelheim Vetmedica Gmbh Kit d'éléments

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0069097A2 (fr) * 1981-06-18 1983-01-05 Astra Läkemedel Aktiebolag Mélange pharmaceutique
GB2122490A (en) * 1982-06-24 1984-01-18 Astra Laekemedel Ab Controlled release formulation
WO1993000898A1 (fr) * 1991-07-11 1993-01-21 Smithkline Beecham Plc Formulation pharmaceutique comprenant une beta-lactamine et de l'acide clavulanique ou un sel de celui-ci soluble dans l'eau
EP0551820A1 (fr) * 1992-01-15 1993-07-21 Bayer Ag Compositions pharmaceutiques masquant le mauvais goût
WO1993017667A1 (fr) * 1992-03-12 1993-09-16 Taisho Pharmaceutical Co., Ltd. Composition pour preparations buvables
WO1996001628A1 (fr) * 1994-07-07 1996-01-25 Recordati Industria Chimica E Farmaceutica S.P.A. Composition pharmaceutique pour la liberation regulee de moguisteine sous forme de suspension liquide

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0069097A2 (fr) * 1981-06-18 1983-01-05 Astra Läkemedel Aktiebolag Mélange pharmaceutique
GB2122490A (en) * 1982-06-24 1984-01-18 Astra Laekemedel Ab Controlled release formulation
WO1993000898A1 (fr) * 1991-07-11 1993-01-21 Smithkline Beecham Plc Formulation pharmaceutique comprenant une beta-lactamine et de l'acide clavulanique ou un sel de celui-ci soluble dans l'eau
EP0551820A1 (fr) * 1992-01-15 1993-07-21 Bayer Ag Compositions pharmaceutiques masquant le mauvais goût
WO1993017667A1 (fr) * 1992-03-12 1993-09-16 Taisho Pharmaceutical Co., Ltd. Composition pour preparations buvables
WO1996001628A1 (fr) * 1994-07-07 1996-01-25 Recordati Industria Chimica E Farmaceutica S.P.A. Composition pharmaceutique pour la liberation regulee de moguisteine sous forme de suspension liquide

Also Published As

Publication number Publication date
AU6092698A (en) 1998-09-09
EP0971691A2 (fr) 2000-01-19
DE19706978A1 (de) 1998-08-27
WO1998036732A2 (fr) 1998-08-27

Similar Documents

Publication Publication Date Title
CA2251886A1 (fr) Preparation pharmaceutique orale contenant de l'ibandronate
CA2225960A1 (fr) Compositions pharmaceutiques
CA2253811A1 (fr) Suspensions liquides a gout masque
CA2193337A1 (fr) Composes de type 1-phenyl-2-dimethylaminomethylcyclohexan-1-o1, ingredients pharmaceutiques actifs
CA2163706A1 (fr) Derives amino-acides de paclitaxel
CA2170622A1 (fr) Formulations orales pour un antifongique
CA2258095A1 (fr) Compositions contenant de la tetrahydrolipstatine
CA2203033A1 (fr) Composes et compositions pour l'administration d'agents actifs
CA2337046A1 (fr) Preparation pharmaceutique a liberation prolongee
IE881452L (en) Pharmaceutical composition
EP1731140A3 (fr) Formulation d'aerosol medicinal
CA2024631A1 (fr) Granules a double enrobage
HUP9800813A3 (en) Lactam-containing hydroxamic acid derivatives, their preparation and pharmaceutical compositions containing them
WO2001027109A3 (fr) Derives de tert.-butyl-(methyl-imidazo[1,2-a]pyridine-3-yl)amine
AU3345197A (en) Stable drug form for oral administration with benzimidazole derivatives as active ingredient and process for the preparation thereof
AU2002238947A1 (en) Triazaspiro[5.5]undecane derivatives and drugs containing the same as the active ingredient
AU5651696A (en) Substituted 1-phenyl-3-pyrazolecarboxamides active on nurotensin receptors, their preparation and pharmaceutical compositions containing them
CA2292673A1 (fr) Compositions pharmaceutiques contenant hemisulfate d'eletriptane
CA2164776A1 (fr) Composition pharmaceutique, administrable par voie orale
CA2175971A1 (fr) Composition liquide stable renfermant de l'urate-oxydase; composition lyophilisee pour sa preparation
CA2338794A1 (fr) Nouvelle formulation orale d'agonistes ou d'antagonistes de 5-ht4
AU7694896A (en) Prompt-release pharmaceutical compositions
CA2376894A1 (fr) Composition pharmaceutique comprenant une proteine et une ectoine
AU7306096A (en) Aryl-piperazine cyclic amine derivatives, preparation thereof and pharmaceutical compositions containing same
WO1998036732A3 (fr) Preparation combinee pour antibiotiques administrables par voie orale

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE GH GM GW HU ID IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW SD SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE SN TD TG

AK Designated states

Kind code of ref document: A3

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE GH GM GW HU ID IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW SD SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 1998905269

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 1998905269

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: JP

Ref document number: 1998536182

Format of ref document f/p: F

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWW Wipo information: withdrawn in national office

Ref document number: 1998905269

Country of ref document: EP